Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

US Patent 11491216 · Granted Nov 8, 2022

Estimated economic value: $310,648,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conj2025
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier2024
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier2024